Lixisenatide - Therapy in Patients with Type-2-Diabetes and acute Coronary Syndrome

被引：0
|
作者：
Kahl, S. [1 ]
机构：
[1] Univ Dusseldorf, Inst Klin Diabetol, Deutsch Diabet Zentrum, Leibniz Zentrum Diabet Forsch, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany
来源：
DIABETOLOGE | 2016年 / 12卷 / 01期
关键词：
D O I：
10.1007/s11428-015-0055-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [1] Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
    Pfeffer, Marc A.
    Claggett, Brian
    Diaz, Rafael
    Dickstein, Kenneth
    Gerstein, Hertzel C.
    Kober, Lars V.
    Lawson, Francesca C.
    Ping, Lin
    Wei, Xiaodan
    Lewis, Eldrin F.
    Maggioni, Aldo P.
    McMurray, John J. V.
    Probstfield, Jeffrey L.
    Riddle, Matthew C.
    Solomon, Scott D.
    Tardif, Jean-Claude
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (23): : 2247 - 2257
  • [2] Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome
    Tsutsumi, Yusuke
    Tsujimoto, Yasushi
    Ikenoue, Tatsuyoshi
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11): : 1094 - 1095
  • [3] Therapy for Patients with Type-2-Diabetes
    Landgraf, Ruediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald H.
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Siegel, Erhard
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2020, 15 : S65 - S92
  • [4] INSULIN, LIXISENATIDE, AND RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES AND A RECENT ACUTE CORONARY SYNDROME
    Aguilar, David
    Pfeffer, Marc A.
    Claggett, Brian
    Liu, Jiankang
    McMurray, John
    Tardif, Jean Claude
    Dickstein, Kenneth
    Kober, Lars
    Diaz, Rafael
    Solomon, Scott D.
    Saremi, Aramesh
    Riddle, Matthew
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 94 - 94
  • [5] Atorvastatin Therapy in Type-2-Diabetes Patients
    Kahl, S.
    [J]. DIABETOLOGE, 2015, 11 (04): : 327 - 328
  • [6] Type-2-diabetes: Therapy of hospitalized patients
    Kellerer, Monika
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (01) : 24 - 24
  • [7] Effects of lixisenatide on natriuretic peptides in patients with diabetes and acute coronary syndrome
    Tardif, J. -C.
    Diaz, R.
    Dickstein, K.
    Gerstein, H. C.
    Kober, L. V.
    Lawson, F. C.
    Lewis, E. F.
    Maggioni, A. P.
    McMurray, J. J. V.
    Probstfield, J. L.
    Riddle, M. C.
    Solomon, S. D.
    Claggett, B. L.
    Pfeffer, M. A.
    [J]. DIABETOLOGIA, 2016, 59 : S515 - S515
  • [8] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Siegel, Erhard
    [J]. DIABETOLOGE, 2021, 17 (04): : 422 - 447
  • [9] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Kellerer, Monika
    Fach, Eva-Maria
    Gallwitz, Baptist
    Hamann, Andreas
    Joost, Hans-Georg
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Schreiber, Stephan
    Siegel, Erhard
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 : S141 - S156
  • [10] Lixisenatid-Therapie bei Patienten mit Typ-2-Diabetes und akutem KoronarsyndromLixisenatide therapy in patients with type-2-diabetes and acute coronary syndrome
    S. Kahl
    [J]. Der Diabetologe, 2016, 12 : 42 - 43
12345